DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP)

27.43 0.30 (1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NPSP $27.43 1.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.02
Previous Close $27.13
Daily Range $26.49 - $27.70
52-Week Range $21.60 - $39.68
Market Cap $2.9B
P/E Ratio 678.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,733,090
Average Daily Volume 2,481,843
Current FY EPS $0.03

Sector

Healthcare

Industry

Drugs

NPS Pharmaceuticals, Inc. (NPSP) Description

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins. Website: http://www.npsp.com/

News & Commentary

Why NPS Pharmaceuticals, Inc. Stock Plunged

NPS Pharmaceuticals' stock is among today's top losers after announcing the results of the FDA panel's vote on whether or not to recommend approval for experimental hypoparathyroidism drug Natpara. Find out what this news means for NPS' shareholders.

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog

Technology Stocks Down As Rest Of The Market Starts Week Flat

Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge

Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge

Monday Sector Laggards: Biotechnology, Application Software Stocks

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

Sector Update: Health-Care Shares Lower Pre-Market

See More NPSP News...

NPSP's Top Competitors

NPSP $27.43 (1.11%)
Current stock: NPSP
AMGN $142.18 (-1.27%)
Current stock: AMGN
GILD $105.47 (-0.46%)
Current stock: GILD
BIIB $329.76 (0.16%)
Current stock: BIIB